The effectiveness of GLP-1 agonists in facilitating weight loss has made them a popular choice among healthcare providers
Your body naturally produces GLP-1 after you eat
According to the Bay Area biotech, its oral once-daily glucagon-like peptide-1 (GLP-1) drug candidate, aleniglipron, demonstrated an absolute weight loss of up to 39 pounds in the 44-week Access II trial
In Summary GLP1 medications do more than reduce appetitethey reshape gut microbiota
These changes could make the optic nerve more vulnerable to damage
"Really only after a drug gets on the market, and sometimes after it's been on the market for many years, do we fully understand a more complete picture of the characteristics of that drug," said Kristine Steffen, NDSU professor of pharmaceutical sciences